Siddiqui JA, Partridge NC. Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement. Physiol (Bethesda). 2016;31(3):233–45. https://doi.org/10.1152/physiol.00061.2014.

Article  Google Scholar 

Yang N, Liu Y. The Role of the Immune Microenvironment in Bone Regeneration. Int J Med Sci. 2021;18(16):3697–707. https://doi.org/10.7150/ijms.61080.

Article  PubMed  PubMed Central  Google Scholar 

Lorenzo J, Horowitz M, Choi Y. Osteoimmunology: interactions of the bone and immune system. Endocr Rev. 2008;29(4):403–40. https://doi.org/10.1210/er.2007-0038.

Article  PubMed  PubMed Central  Google Scholar 

Arron JR, Choi Y. Bone versus immune system. Nature. 2000;408(6812):535–6. https://doi.org/10.1038/35046196.

Article  PubMed  Google Scholar 

Weitzmann MN. Bone and the Immune System. Toxicol Pathol. 2017;45(7):911–24. https://doi.org/10.1177/0192623317735316.

Article  PubMed  PubMed Central  Google Scholar 

Charles JF, Nakamura MC. Bone and the innate immune system. Curr Osteoporos Rep. 2014;12(1):1–8. https://doi.org/10.1007/s11914-014-0195-2.

Article  PubMed  PubMed Central  Google Scholar 

Hardy R, Cooper MS. Bone loss in inflammatory disorders. J Endocrinol. 2009;201(3):309–20. https://doi.org/10.1677/JOE-08-0568.

Article  PubMed  Google Scholar 

Redlich K, Smolen JS. Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov. 2012;11(3):234–50. https://doi.org/10.1038/nrd3669.

Article  PubMed  Google Scholar 

Jeong E, Lee JY. Intrinsic and extrinsic regulation of innate immune receptors. Yonsei Med J. 2011;52(3):379–92. https://doi.org/10.3349/ymj.2011.52.3.379.

Article  PubMed  PubMed Central  Google Scholar 

Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009;22(2):240–73. https://doi.org/10.1128/CMR.00046-08. Table of Contents.

Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT. PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev. 2012;249(1):158–75. https://doi.org/10.1111/j.1600-065X.2012.01146.x.

Article  PubMed  PubMed Central  Google Scholar 

Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9(6):7204–18. https://doi.org/10.18632/oncotarget.23208.

Article  PubMed  Google Scholar 

Guder C, Gravius S, Burger C, Wirtz DC, Schildberg FA, Osteoimmunology. A Current Update of the Interplay Between Bone and the Immune System. Front Immunol. 2020;11:58. https://doi.org/10.3389/fimmu.2020.00058.

Article  PubMed  PubMed Central  Google Scholar 

Abbas S, Zhang YH, Clohisy JC, Abu-Amer Y. Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1 receptor. Cytokine. 2003;22(1–2):33–41. https://doi.org/10.1016/s1043-4666(03)00106-6.

Article  PubMed  Google Scholar 

Krauss JL, Roper PM, Ballard A, Shih CC, Fitzpatrick JAJ, Cassat JE, et al. Staphylococcus aureus Infects Osteoclasts and Replicates Intracellularly. mBio. 2019;10(5). https://doi.org/10.1128/mBio.02447-19.

Cremet L, Broquet A, Brulin B, Jacqueline C, Dauvergne S, Brion R, et al. Pathogenic potential of Escherichia coli clinical strains from orthopedic implant infections towards human osteoblastic cells. Pathog Dis. 2015;73(8):ftv065. https://doi.org/10.1093/femspd/ftv065.

Article  PubMed  PubMed Central  Google Scholar 

Murillo O, Roset A, Sobrino B, Lora-Tamayo J, Verdaguer R, Jimenez-Mejias E, et al. Streptococcal vertebral osteomyelitis: multiple faces of the same disease. Clin Microbiol Infect. 2014;20(1):O33–8. https://doi.org/10.1111/1469-0691.12302.

Article  PubMed  Google Scholar 

Saxena Y, Routh S, Mukhopadhaya A, Immunoporosis. Role of Innate Immune Cells in Osteoporosis. Front Immunol. 2021;12:687037. https://doi.org/10.3389/fimmu.2021.687037.

Article  PubMed  PubMed Central  Google Scholar 

Fitzgerald KA, Kagan JC. Toll-like Receptors and the Control of Immunity. Cell. 2020;180(6):1044–66. https://doi.org/10.1016/j.cell.2020.02.041.

Article  PubMed  PubMed Central  Google Scholar 

Yu L, Wang L, Chen S. Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med. 2010;14(11):2592–603. https://doi.org/10.1111/j.1582-4934.2010.01127.x.

Article  PubMed  PubMed Central  Google Scholar 

Liu T, Zhang L, Joo D, Sun SC. NF-kappaB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023. https://doi.org/10.1038/sigtrans.2017.23.

Article  PubMed  PubMed Central  Google Scholar 

Takami M, Kim N, Rho J, Choi Y. Stimulation by toll-like receptors inhibits osteoclast differentiation. J Immunol. 2002;169(3):1516–23. https://doi.org/10.4049/jimmunol.169.3.1516.

Article  PubMed  Google Scholar 

He X, Wang H, Jin T, Xu Y, Mei L, Yang J. TLR4 Activation Promotes Bone Marrow MSC Proliferation and Osteogenic Differentiation via Wnt3a and Wnt5a Signaling. PLoS ONE. 2016;11(3):e0149876. https://doi.org/10.1371/journal.pone.0149876.

Article  PubMed  PubMed Central  Google Scholar 

Zhou Z, Han JY, Xi CX, Xie JX, Feng X, Wang CY, et al. HMGB1 regulates RANKL-induced osteoclastogenesis in a manner dependent on RAGE. J Bone Min Res. 2008;23(7):1084–96. https://doi.org/10.1359/jbmr.080234.

Article  Google Scholar 

Koh JM, Lee YS, Kim YS, Park SH, Lee SH, Kim HH, et al. Heat shock protein 60 causes osteoclastic bone resorption via toll-like receptor-2 in estrogen deficiency. Bone. 2009;45(4):650–60. https://doi.org/10.1016/j.bone.2009.06.007.

Article  PubMed  Google Scholar 

Ji JD, Park-Min KH, Shen Z, Fajardo RJ, Goldring SR, McHugh KP, et al. Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors. J Immunol. 2009;183(11):7223–33. https://doi.org/10.4049/jimmunol.0900072.

Article  PubMed  Google Scholar 

AlQranei MS, Senbanjo LT, Aljohani H, Hamza T, Chellaiah MA, Lipopolysaccharide-. TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling. BMC Immunol. 2021;22(1):23. https://doi.org/10.1186/s12865-021-00409-9. * Demonstrated the requirement of prior RANKL signaling and TNF-α secretion for LPS-induced osteoclast differentiation.

Tominari T, Sanada A, Ichimaru R, Matsumoto C, Hirata M, Itoh Y et al. Gram-positive bacteria cell wall-derived lipoteichoic acid induces inflammatory alveolar bone loss through prostaglandin E production in osteoblasts. Sci Rep. 2021;11(1):13353. doi: 10.1038/s41598-021-92744-5. * First study to show Gram-positive bacteria cell wall component lipoteichoic acid can promote periodontitis by inducing PGE2 expression in osteoblasts.

Yim M. The Role of Toll-Like Receptors in Osteoclastogenesis. J Bone Metab. 2020;27(4):227–35. https://doi.org/10.11005/jbm.2020.27.4.227.

Article  PubMed  PubMed Central  Google Scholar 

van den Berk LC, Jansen BJ, Siebers-Vermeulen KG, Netea MG, Latuhihin T, Bergevoet S, et al. Toll-like receptor triggering in cord blood mesenchymal stem cells. J Cell Mol Med. 2009;13(9B):3415–26. https://doi.org/10.1111/j.1582-4934.2009.00653.x.

Article  PubMed  Google Scholar 

Bryant CE, Symmons M, Gay NJ. Toll-like receptor signalling through macromolecular protein complexes. Mol Immunol. 2015;63(2):162–5. https://doi.org/10.1016/j.molimm.2014.06.033.

Article  PubMed  Google Scholar 

Hegewald AB, Breitwieser K, Ottinger SM, Mobarrez F, Korotkova M, Rethi B, et al. Extracellular miR-574-5p Induces Osteoclast Differentiation via TLR 7/8 in Rheumatoid Arthritis. Front Immunol. 2020;11:585282. https://doi.org/10.3389/fimmu.2020.585282.

Article  PubMed  PubMed Central  Google Scholar 

Niu Q, Gao J, Wang L, Liu J, Zhang L. Regulation of differentiation and generation of osteoclasts in rheumatoid arthritis. Front Immunol. 2022;13:1034050. https://doi.org/10.3389/fimmu.2022.1034050.

Article  PubMed  PubMed Central  Google Scholar 

Kim KW, Kim BM, Won JY, Lee KA, Kim HR, Lee SH. Toll-like receptor 7 regulates osteoclastogenesis in rheumatoid arthritis. J Biochem. 2019;166(3):259–70. https://doi.org/10.1093/jb/mvz033.